NO905067D0 - Nye isoindolonderivater og deres fremstilling. - Google Patents

Nye isoindolonderivater og deres fremstilling.

Info

Publication number: NO905067D0
Authority: NO; Norway
Prior art keywords: derivatives; preparation; new; isoindolond; radicals
Prior art date: 1989-11-23

Application number

NO905067A

Other languages

English (en)

Other versions

NO174148B (no

NO905067L (no

NO174148C (no

Inventor

Marie-Christine Dubroeucq

Claude Moutonnier

Jean-Francois Peyronel

Michel Tabart

Alain Truchon

Original Assignee

Rhone Poulenc Sante

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-23

Filing date

1990-11-22

Publication date

1990-11-22

1990-11-22 Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante

1990-11-22 Publication of NO905067D0 publication Critical patent/NO905067D0/no

1991-05-24 Publication of NO905067L publication Critical patent/NO905067L/no

1993-12-13 Publication of NO174148B publication Critical patent/NO174148B/no

1994-03-23 Publication of NO174148C publication Critical patent/NO174148C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pulmonology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Indole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

NO905067A 1989-11-23 1990-11-22 Nye isoindolonderivater NO174148C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8915407A FR2654726B1 (fr)	1989-11-23	1989-11-23	Nouveaux derives de l'isoindolone et leur preparation.

Publications (4)

Publication Number	Publication Date
NO905067D0 true NO905067D0 (no)	1990-11-22
NO905067L NO905067L (no)	1991-05-24
NO174148B NO174148B (no)	1993-12-13
NO174148C NO174148C (no)	1994-03-23

Family

ID=9387708

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO905067A NO174148C (no)	1989-11-23	1990-11-22	Nye isoindolonderivater

Country Status (23)

Country	Link
US (1)	US5112988A (no)
EP (1)	EP0430771B1 (no)
JP (1)	JPH03176468A (no)
KR (1)	KR910009660A (no)
AT (1)	ATE108774T1 (no)
AU (1)	AU635984B2 (no)
CA (1)	CA2030570A1 (no)
DE (1)	DE69010851T2 (no)
DK (1)	DK0430771T3 (no)
ES (1)	ES2057488T3 (no)
FI (1)	FI94627C (no)
FR (1)	FR2654726B1 (no)
HU (1)	HU214574B (no)
IE (1)	IE64737B1 (no)
IL (1)	IL96447A (no)
NO (1)	NO174148C (no)
NZ (1)	NZ236175A (no)
PL (2)	PL164955B1 (no)
PT (1)	PT95983B (no)
RU (1)	RU2104269C1 (no)
SK (1)	SK278474B6 (no)
YU (1)	YU47437B (no)
ZA (1)	ZA909370B (no)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2676442B1 (fr) *	1991-05-17	1993-08-06	Rhone Poulenc Rorer Sa	Nouveau derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2688219B1 (fr)	1992-03-03	1994-07-08	Sanofi Elf	Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
FR2689889B1 (fr) *	1992-04-10	1994-06-10	Rhone Poulenc Rorer Sa	Nouveaux derives de perhydroisoindole, et leur preparation.
US5830854A (en) *	1992-12-14	1998-11-03	Merck Sharp & Dohme, Limited	Method of treating cystic fibrosis using a tachykinin receptor antagonist
FR2703679B1 (fr) *	1993-04-05	1995-06-23	Rhone Poulenc Rorer Sa	Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
TW365603B (en) *	1993-07-30	1999-08-01	Rhone Poulenc Rorer Sa	Novel perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
FR2710913B1 (fr) *	1993-10-07	1995-11-24	Rhone Poulenc Rorer Sa	Nouveaux dérivés de perhydroisoindole, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2709752B1 (fr) *	1993-07-30	1995-10-06	Rhone Poulenc Rorer Sa	Nouveaux dérivés de perhydroisoindole, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5543530A (en) *	1993-12-23	1996-08-06	Ortho Pharmaceutical Corporation	4-arylisoindole analgesics
FR2728166A1 (fr)	1994-12-19	1996-06-21	Oreal	Composition topique contenant un antagoniste de substance p
FR2728165A1 (fr)	1994-12-19	1996-06-21	Oreal	Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728169A1 (fr)	1994-12-19	1996-06-21	Oreal	Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2729954B1 (fr)	1995-01-30	1997-08-01	Sanofi Sa	Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2741262B1 (fr)	1995-11-20	1999-03-05	Oreal	Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
FR2755013B1 (fr) *	1996-10-29	1998-11-27	Rhone Poulenc Rorer Sa	Nouvelle application therapeutique des antagonistes de la substance p
WO2001032625A1 (en)	1999-11-03	2001-05-10	Du Pont Pharmaceuticals Company	Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
US7163949B1 (en)	1999-11-03	2007-01-16	Amr Technology, Inc.	4-phenyl substituted tetrahydroisoquinolines and use thereof
CA2415532C (en)	2000-07-11	2010-05-11	Albany Molecular Research, Inc.	Novel 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
UA91341C2 (ru)	2004-07-15	2010-07-26	Амр Текнолоджи, Інк.	Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
WO2006123182A2 (en)	2005-05-17	2006-11-23	Merck Sharp & Dohme Limited	Cyclohexyl sulphones for treatment of cancer
NZ565111A (en)	2005-07-15	2011-10-28	Amr Technology Inc	Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
GB0603041D0 (en)	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
US20110218176A1 (en)	2006-11-01	2011-09-08	Barbara Brooke Jennings-Spring	Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
EP2805945B1 (en)	2007-01-10	2019-04-03	MSD Italia S.r.l.	Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
AU2008269154B2 (en)	2007-06-27	2014-06-12	Merck Sharp & Dohme Llc	4-carboxybenzylamino derivatives as histone deacetylase inhibitors
AR071997A1 (es)	2008-06-04	2010-07-28	Bristol Myers Squibb Co	Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
US8691825B2 (en)	2009-04-01	2014-04-08	Merck Sharp & Dohme Corp.	Inhibitors of AKT activity
KR20120023072A (ko)	2009-05-12	2012-03-12	브리스톨-마이어스 스큅 컴퍼니	（Ｓ）-7-（〔1,2,4〕트리아졸〔1,5-ａ〕피리딘-6-일）-4-（3,4-디클로로페닐）-1,2,3,4-테트라하이드로이소퀴놀린의 결정형 및 이의 용도
EA020553B1 (ru)	2009-05-12	2014-12-30	Олбани Молекьюлар Рисерч, Инк.	7-([1,2,4]ТРИАЗОЛО[1,5-α]ПИРИДИН-6-ИЛ)-4-(3,4-ДИХЛОРФЕНИЛ)-1,2,3,4-ТЕТРАГИДРОИЗОХИНОЛИН, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ И СПОСОБЫ ЛЕЧЕНИЯ НЕВРОЛОГИЧЕСКИХ И ПСИХИЧЕСКИХ РАССТРОЙСТВ
EP2429295B1 (en)	2009-05-12	2013-12-25	Albany Molecular Research, Inc.	Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
CN102638981B (zh)	2009-10-14	2015-07-22	默沙东公司	提高p53活性的取代的哌啶和其用途
BR112012018897A2 (pt) *	2010-01-27	2017-10-03	Ab Pharma Ltd	Compostos poli-heterocíclicos altamente potentes como inibidores de hcv
EP2601293B1 (en)	2010-08-02	2017-12-06	Sirna Therapeutics, Inc.	RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2012024170A2 (en)	2010-08-17	2012-02-23	Merck Sharp & Dohme Corp.	RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
EP2608669B1 (en)	2010-08-23	2016-06-22	Merck Sharp & Dohme Corp.	NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
WO2012030685A2 (en)	2010-09-01	2012-03-08	Schering Corporation	Indazole derivatives useful as erk inhibitors
US9242981B2 (en)	2010-09-16	2016-01-26	Merck Sharp & Dohme Corp.	Fused pyrazole derivatives as novel ERK inhibitors
EP3766975A1 (en)	2010-10-29	2021-01-20	Sirna Therapeutics, Inc.	Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
WO2012087772A1 (en)	2010-12-21	2012-06-28	Schering Corporation	Indazole derivatives useful as erk inhibitors
IN2013MN02170A (no)	2011-04-21	2015-06-12	Piramal Entpr Ltd
US9023865B2 (en)	2011-10-27	2015-05-05	Merck Sharp & Dohme Corp.	Compounds that are ERK inhibitors
EP3919620A1 (en)	2012-05-02	2021-12-08	Sirna Therapeutics, Inc.	Short interfering nucleic acid (sina) compositions
RU2660429C2 (ru)	2012-09-28	2018-07-06	Мерк Шарп И Доум Корп.	Новые соединения, которые являются ингибиторами erk
PL2925888T3 (pl)	2012-11-28	2018-03-30	Merck Sharp & Dohme Corp.	Kompozycje i sposoby do stosowania w leczeniu nowotworów
KR102196882B1 (ko)	2012-12-20	2020-12-30	머크 샤프 앤드 돔 코포레이션	Hdm2 억제제로서의 치환된 이미다조피리딘
WO2014120748A1 (en)	2013-01-30	2014-08-07	Merck Sharp & Dohme Corp.	2,6,7,8 substituted purines as hdm2 inhibitors
US20160194368A1 (en)	2013-09-03	2016-07-07	Moderna Therapeutics, Inc.	Circular polynucleotides
EP3525785B1 (en)	2016-10-12	2025-08-27	Merck Sharp & Dohme LLC	Kdm5 inhibitors
EP3706747B1 (en)	2017-11-08	2025-09-03	Merck Sharp & Dohme LLC	Prmt5 inhibitors
US10947234B2 (en)	2017-11-08	2021-03-16	Merck Sharp & Dohme Corp.	PRMT5 inhibitors
MA53287A (fr)	2018-08-07	2022-05-11	Merck Sharp & Dohme	Inhibiteurs de prmt5
WO2020033284A1 (en)	2018-08-07	2020-02-13	Merck Sharp & Dohme Corp.	Prmt5 inhibitors
EP3833668B1 (en)	2018-08-07	2025-03-19	Merck Sharp & Dohme LLC	Prmt5 inhibitors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2858314A (en) *	1954-06-07	1958-10-28	Georgian Vlasios	Hydrocarbazolenines
US4042707A (en) *	1976-02-19	1977-08-16	E. I. Du Pont De Nemours And Company	3α-Arylhydroisoindoles
IT1113879B (it) *	1979-03-15	1986-01-27	Farmatis Spa	Derivato isoindolinico,processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo
US4494547A (en) *	1981-03-30	1985-01-22	North Carolina Central University	2H-isoindolediones, their synthesis and use as radiosensitizers
DE3133302A1 (de) *	1981-08-22	1983-03-03	Beiersdorf Ag, 2000 Hamburg	Isoindolin-2-yl-amino-imidazoline und isoindolin-2-yl-guanidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
EP0091241B1 (en) *	1982-04-02	1988-12-28	Takeda Chemical Industries, Ltd.	Condensed pyrrolinone derivatives, and their production
ATE87307T1 (de) *	1985-12-09	1993-04-15	Banyu Pharma Co Ltd	Isoindolinderivate und verfahren zu ihrer herstellung.

1989
- 1989-11-23 FR FR8915407A patent/FR2654726B1/fr not_active Expired - Lifetime
1990
- 1990-11-20 US US07/616,044 patent/US5112988A/en not_active Expired - Fee Related
- 1990-11-21 NZ NZ236175A patent/NZ236175A/xx unknown
- 1990-11-22 KR KR1019900019099A patent/KR910009660A/ko not_active Abandoned
- 1990-11-22 IL IL9644790A patent/IL96447A/en not_active IP Right Cessation
- 1990-11-22 SK SK5806-90A patent/SK278474B6/sk unknown
- 1990-11-22 EP EP90403300A patent/EP0430771B1/fr not_active Expired - Lifetime
- 1990-11-22 NO NO905067A patent/NO174148C/no unknown
- 1990-11-22 ES ES90403300T patent/ES2057488T3/es not_active Expired - Lifetime
- 1990-11-22 AU AU66828/90A patent/AU635984B2/en not_active Ceased
- 1990-11-22 HU HU907249A patent/HU214574B/hu not_active IP Right Cessation
- 1990-11-22 DE DE69010851T patent/DE69010851T2/de not_active Expired - Fee Related
- 1990-11-22 ZA ZA909370A patent/ZA909370B/xx unknown
- 1990-11-22 AT AT90403300T patent/ATE108774T1/de not_active IP Right Cessation
- 1990-11-22 FI FI905770A patent/FI94627C/fi not_active IP Right Cessation
- 1990-11-22 IE IE423490A patent/IE64737B1/en not_active IP Right Cessation
- 1990-11-22 JP JP2320570A patent/JPH03176468A/ja active Pending
- 1990-11-22 CA CA002030570A patent/CA2030570A1/fr not_active Abandoned
- 1990-11-22 DK DK90403300.8T patent/DK0430771T3/da active
- 1990-11-23 YU YU223590A patent/YU47437B/sh unknown
- 1990-11-23 PL PL90301462A patent/PL164955B1/pl unknown
- 1990-11-23 PL PL90287908A patent/PL164973B1/pl unknown
- 1990-11-23 PT PT95983A patent/PT95983B/pt not_active IP Right Cessation
1992
- 1992-12-01 RU RU92004482A patent/RU2104269C1/ru active

Also Published As

Publication number	Publication date
JPH03176468A (ja)	1991-07-31
PT95983B (pt)	1998-01-30
NO174148B (no)	1993-12-13
CA2030570A1 (fr)	1991-05-24
YU223590A (sh)	1993-05-28
DE69010851D1 (de)	1994-08-25
HUT55756A (en)	1991-06-28
KR910009660A (ko)	1991-06-28
DK0430771T3 (da)	1994-08-29
FR2654726A1 (fr)	1991-05-24
NZ236175A (en)	1993-03-26
FI905770L (fi)	1991-05-24
NO905067L (no)	1991-05-24
EP0430771A1 (fr)	1991-06-05
FR2654726B1 (fr)	1992-02-14
FI94627B (fi)	1995-06-30
ES2057488T3 (es)	1994-10-16
RU2104269C1 (ru)	1998-02-10
PL164973B1 (pl)	1994-10-31
PT95983A (pt)	1991-09-13
IL96447A (en)	1995-03-15
IE904234A1 (en)	1991-06-05
SK580690A3 (en)	1997-07-09
ATE108774T1 (de)	1994-08-15
IE64737B1 (en)	1995-09-06
DE69010851T2 (de)	1994-11-24
PL164955B1 (en)	1994-10-31
US5112988A (en)	1992-05-12
AU635984B2 (en)	1993-04-08
FI905770A0 (fi)	1990-11-22
IL96447A0 (en)	1991-08-16
SK278474B6 (en)	1997-07-09
HU214574B (hu)	1998-04-28
NO174148C (no)	1994-03-23
ZA909370B (en)	1991-10-30
HU907249D0 (en)	1991-05-28
AU6682890A (en)	1991-05-30
YU47437B (sh)	1995-03-27
PL287908A1 (en)	1991-12-02
EP0430771B1 (fr)	1994-07-20
FI94627C (fi)	1995-10-10

Publication	Publication Date	Title
NO905067L (no)	1991-05-24	Nye isoindolonderivater og deres fremstilling.
RU92004482A (ru)	1995-06-19	Производные изоиндола
DK0586471T3 (da)	1995-06-06	Perhydroisoindolderivater og deres fremstilling
MX9301986A (es)	1994-05-31	Derivados de perhidroisoindol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DK213290D0 (da)	1990-09-06	Treatment of cerebrovascular disorders
DK165953C (da)	1993-07-05	Fremgangsmaade til fremstilling af 2,3-dihydrobenzofuranderivater
DK327286D0 (da)	1986-07-10	Indolcarboxamidderivater og salte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter til deres fremstilling
DK0470686T3 (da)	1996-08-26	(Benzhydryloxyethylpiperidyl)alifatiske syrederivater og deres anvendelse til behandling af allergier og astma
FI861324A0 (fi)	1986-03-26	Nya (4.2.0) bicyclooktanderivat, som har vaerdefulla terapeutiska egenskaper.
DK228086A (da)	1986-11-18	Substituerede isoxazol-derivater med antiviral virkning og fremgangsmaade af saadanne derivater
PT79273A (en)	1984-10-01	2-(n-pyrrolidino)-3-isobutoxy-n-substituted-phenyl-n-benzil-propylamines their preparation and pharmaceutical use
ES2042727T3 (es)	1993-12-16	Acidos 1,3,4,9-tetrahidropirano(3,4-b)indol-1-acetico.
ES531318A0 (es)	1985-05-16	Procedimiento para la obtencion de derivados quinolinicos
DK356287D0 (da)	1987-07-09	2,6-piperazindionderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende disse
DK104488D0 (da)	1988-02-26	Acetamider afledt af 2,3-dihydro-3-phenyl-2-benzofuranon, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem